Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-24 @ 9:59 PM
NCT ID:
NCT04669132
Eligibility Criteria:
Inclusion Criteria:
* Breast cancer hitologically confirmed
* 18 Years and older (Adult, Older Adult)
* Patients about to start use of Doxorubicine 60mg/m2 + Cyclophosfamide 600mg/m2
* No previous chemotherapy for breast cancer
Exclusion Criteria:
* Patients not capable of completing the questionnaire
* Patients with other condition that could cause nausea and emesis
* Use of opioids
* Use of antipsychotic medications
* Patients not capable of taking medications orally
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04669132
Study Brief:
Protocol Section:
NCT04669132